Enter Symbol:

Stock Detail

PFIZER INC

Dow Jones 30 Index

PFE @ Yahoo Finance | PFE Option @ Yahoo Finance

Last Day's Data

Current Price High Value Change Percent Change Dividend Previous Close
$19.57 $19.94 $0.00 0.00% 0.80 $19.87
Opening Price Low Volume Market Cap Average Volume P/E
$19.65 $19.53 35.21M 150.43B 47.27M 13.59

Pivot Table

R2 R1 Pivot S1 S2
20.09 19.83 19.68 19.42 19.27

stock chart

Stock Profile

Pfizer, Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals, as well as consumer healthcare products worldwide. It operates in three segments: Human Health, Consumer Healthcare, and Animal Health. The Human Health segment offers treatments for cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye disease, endocrine disorders, and allergies. The Consumer Healthcare segment markets over-the-counter medications for oral care, upper respiratory health, tobacco dependence, gastrointestinal health, skin care, eye care, and hair growth. Its principal products include Listerine mouthwash, Listerine PocketPaks oral care strips, Nicorette for tobacco dependence, Benadryl antihistamine for allergies, Sudafed for sinus congestion, Rogaine for hair growth, Zantac 75 for prevention and relief of heartburn, Rolaids antacid tablets, Efferdent denture cleaner, Neosporin antibiotic ointment, Visine eye drops, BenGay topical analgesic, Cortizone skin care products, Lubriderm moisturizing lotions, Unisom sleep aids, Desitin ointments for treatment of diaper rash, Ludens throat drops, and Purell instant hand sanitizer. The Animal Health segment offers products for the prevention and treatment of diseases in livestock and animals. Its products include parasiticides, anti-inflammatories, vaccines, antibiotics, and related medicines. In addition, the company offers empty soft-gelatin capsules, contract manufacturing, and bulk pharmaceutical chemicals. Pfizer has an agreement with Power 3 Medical Products, Inc. to evaluate the NuroPro test capabilities and to test blind and unblinded samples provided by Pfizer; and a research and license agreement with Incyte Corp. for the development, manufacture, and marketing of oral CCR2 antagonists. The company was founded in 1849 and is headquartered in New York City.